Zurich Cantonal Bank’s Verona Pharma VRNA Stock Holding History

Zurich Cantonal Bank’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-162	Closed	-$17.3K	–	3423
2025 Q3	$17.3K	Sell	162 -73	-31%	-$7.62K	﹤0.01%	2482
2025 Q2	$22.2K	Sell	235 -26	-10%	-$1.93K	﹤0.01%	2488
2025 Q1	$16.6K	Buy	+261	New	+$15.6K	﹤0.01%	2565
2024 Q2	–	Sell	-2	Closed	-$32	–	2719
2024 Q1	$32	Sell	2 -519	-100%	-$8.97K	﹤0.01%	2694
2023 Q4	$10.4K	Sell	521 -66	-11%	-$974	﹤0.01%	2677
2023 Q3	$9.57K	Sell	587 -194	-25%	-$3.74K	﹤0.01%	2742
2023 Q2	$16.5K	Sell	781 -200	-20%	-$4.26K	﹤0.01%	2728
2023 Q1	$19.7K	Buy	+981	New	+$21.2K	﹤0.01%	2755

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Zurich Cantonal Bank's VRNA Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 162 shares — an estimated $17.3K sold.

Zurich Cantonal Bank first reported a position in VRNA in Q1 2023 and held it in 8 quarters. The position peaked at $22.2K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Zurich Cantonal Bank reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Zurich Cantonal Bank sold 162 Verona Pharma shares in Q4 2025, an estimated $17.3K.
Zurich Cantonal Bank first reported a position in Verona Pharma in Q1 2023 and held it in 8 quarters.
Zurich Cantonal Bank's Verona Pharma position peaked at $22.2K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.